СИНКОПАЛЬНЫЕ СОСТОЯНИЯ У ДЕТЕЙ И ПОДРОСТКОВ

Рассматриваются основные причины, патофизиологические основы, классификация, методы диагностики и лечения синкопальных состояний у детей и подростков.

синкопальное состояние, кардиомиопатии, каналопатии, холтеровское мониторирование, эхокардиография, стресс-тест, тилт-тест, электрокардиостимулятор, имплантируемый кардиовертер-дефибриллятор, левостороння симпатэктомия, бета-адреноблокаторы

1. Pratt J., Fleisher G. Syncope in children and adolescents. // Pediatr. Emerg. Care. 1989, 5(2): 80-82.

2. Wieling W., Ganzeboom K.S., Saul J.P. Reflex syncope in children and adolescents. // Heart 2004, 90: 1094-1100.

3. Lewis D.A., Dhala A. Syncope in pediatric patient. // Pediatr Clin North Am 1999, 46: 205-19.

4. McHarg M.L., Shinnar S., Rascoff H., Walsh C.A. Syncope in childhood. // Pediatr Cardiol 1997, 18: 367-71.

5. Ritter S., Tani L.Y., Etheridge S.P. et al. What is the yield of screening echocardiography in pediatric syncope? // Pediatrics 2003, 134: 6, E75.

6. Oko-Lagan J., Kuzma J., Pietrucha B. et al. Cardiac syncope in children. // Przegl Lek. 2007, 64: 87-91.

7. Soteriades E., Evans J., Larson M. et al. Incidence and prognosis of syncope. // N. Engl. J. Med. 2002, 347(12): 878-885.

8. Белоконь Н.А., Кубергер М.Б. Болезни сердца и сосудов у детей. Руководство для врачей: в 2 томах. Том 2. - Москва: Медицина. - 1987. - С. 480.

9. Moya A., Sutton R., Ammirati F. et al. Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). // Eur Heart J 2009, 30: 2631-2671.

10. Calkins H. Hypotension and syncope in Braunwald’s Heart Disease, 8th Edn., eds P. Libby, R.O.Bonow, D.L. Mann, and D.P. Zipes (Philadelphia, PA: Saun-ders)2008, 975-983.

11. Grubb B.P Postural tachycardia syndrome. // Circulation 2008, 117: 2814-2817.

12. Goldstein D.S., Holmes C., Frank S.M. et al. Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. // Circulation 2002, 106: 2358-2365.

13. Hainsworth R. Pathophysiology of syncope. // Clin Auton Res. 2004, 14 (1): 18-24.

14. Lambert E., Lambert G. Sympathetic dysfunction in vasovagal syncope and the postural orthostatic tachycardia syndrome. Frontiers in Physiology. // Integrative Physiology 2014, 5 Article280.

15. Medow M.S., Stewart J.M., Sanyal S. et al. Pathophysiology, diagnosis and treatment of orthostatic hypotension and vasovagal syncope. // Cardiol.Rev. 2008, 16: 4-20.

16. Jacob G., Ertl A.C., Shannon J.R. et al. Effect of standing on neurohumoral responses and plasma volume in healthy subjects. // J. Appl.Physiol. 1998, 84: 914-921.

17. Jordan J., Shannon J.R., Diedrich A. Increased sympathetic activation in idiopathic orthostatic intolerance: role of systemic adrenoreceptor sensitivity. // Hypertension 2002, 39: 173-178.

18. Romme J.C.M., Reitsma J.B., Black C.N. et al. Drugs and pacemakers for vasovagal, carotid sinus and situational syncope. // Cochrane Database of Systematic Reviews 2011, 10. Art. No.: CD004194. D0I: 10.1002/14651858. CD004194.pub3.

19. van Dijk J.G., Sheldon R. Is there any point to vasovagal syncope? // Clin Auton Res 2008, 18: 167- 169.

20. Benditt D.G. Neurally mediated syncopal syndromes: pathophysiological concepts and clinical evaluation. // Pacing Clin Electrophysiol. 1997, 20(2 Pt 2): 572-84.

21. Kim B.J., Sung K.C., Kim B.S. et al. Situational syncope induced by belching. // Pacing Clin Electrophysiol. 2005, 28(5): 458-60.

22. O’Donoghue S., Abdallah H. Asystole due to head scratching: a newly confirmed situational syncope. // Heart Rhythm 2013, 10(11): 1728-9.

23. Evans W.N., Acherman R., Kip K., Restrepo H. Hairgrooming syncope in children. // Clin Pediatr (Phila) 2009, 48(8): 834-6.

24. Stephenson J.B. Reflex anoxic seizures (‘white breath-holding’): nonepileptic vagal attacks. // Arch Dis Child 1978, 53: 193-200.

25. DiMario F.J., Burleson J.A. Autonomic nervous system function in severe breath-holding spells. // Pediatr Neurol. 1993, 9: 268-274.

26. DiMario F.J., Chee C.M., Berman P.H. Pallid breath-holding spells. Evaluation of the autonomic nervous system. // ClinPediatr (Phila) 1990, 29: 17-24.

27. Braunwald: Heart Disease: A Textbook of Cardiovascular Medicine, 6th ed., Copyright © 2001 W.B. Saunders Company. Chapter « Syncope and Hipotension» - p.932-940.

28. Elliott P.M., Anastasakis A., Borger M. et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) // European Heart Journal 2014, 35(39): 2733-79.

29. Maron B., Spirito P., Ackerman M. Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy. // J Amer Coll Cardiol 2013, 61: 14: 15271535.

30. O'stman-Smith I Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death. // Fundamental & Clinical Pharmacology 2010, 24: 637.

31. O'stman-Smith I., Wettrell G., Keeton B. et al. Age-and gender specific mortality rates in childhood hypertrophic cardiomyopathy. // Eur Heart J 2008, 29: 1160 - 1167.

32. Efthimiadis G., Pagourelias E., Gossios T., Zegkos T. Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives // World J Cardiol 2014, 6(2): 26-37.

33. Elliott P.M., Gimeno J.R., Tome M.T. et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. // Eur Heart J 2006, 27: 1933-1941.

34. Bockstall K., Link M. A primer on arrhythmias in patients with hypertrophic Cardiomyopathy // Curr Cardiol Rep 2012, 14: 552-562.

35. Barriales-Villa R., Centurion-Inda R., Fernandez-Fernandez X. et al. Severe cardiac conduction disturbances and pacemaker implantation in patients with hypertrophic cardiomyopathy. // Rev Esp Cardiol 2010, 63: 985-988.

36. Prasad K., Williams L., Campbell R. et al. Episodic syncope in hypertrophic cardiomyopathy: evidence for inappropriate vasodilation. // Heart 2008, 94: 1312-1317.

37. Efthimiadis G.K., Parcharidou D.G., Giannakoulas G. et al. Left ventricular out flow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy. // Am J Cardiol 2009, 104: 695-699.

38. Gimeno J.R., Tome-Esteban M., Lofiego C. et al. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. // Eur Heart J 2009, 30: 2599-2605.

39. Maron B.J. Risk Stratification and Role of Implantable Defibrillators for Prevention of Sudden Death in Patients With Hypertrophic Cardiomyopathy. // Circ J 2010, 74: 2271-2282.

40. Zangwill S., Hamilton R. Restrictive cardiomyopathy. // Pacing Clin Electrophysiol. 2009, 32(2): 41-3.

41. Walsh M.A., Grenier M.A., Jefferies J.L. et al. Conduction abnormalities in pediatric patients with restrictive cardiomyopathy // Circ Heart Fail. 2012, 1,5(2): 267-73.

42. Brugada R., Hong K., Dumaine R. et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. // Circulation 2004, 109: 30-35.

43. Bellocq C., van Ginneken A.C., Bezzina C.R. et al. Mutation in the KCNQ1 gene leading to the short QT-in-terval syndrome. // Circulation 2004, 109: 2394-2397.

44. Школьникова М.А. Первичные электрические заболевания сердца как причина внезапной смерти. // Доктор.ru 2008, 3: 25-32.

45. Antzelevitch C., Pollevick G.D., Cordeiro J.M. et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. // Circulation 2007, 115: 442-449.

46. Roden D.M., Lazzara R., Rosen M. et al. Multiple mechanisms in the Long-QT syndrome. Current knowledge, gaps and future direcrions // Circulation 1996, 94: 1996-2012.

47. Schwartz P.J., Locati E., Moss A. et al. Left cardiac sympathethic denervation in therapy of congenital long QT syndrome. A worldwide report. // Circulation 1991, 84: 503-511.

48. Jonsrude C. Current approach to pediatric syncope. // Pediatr Cardiol 2000, 21: 522-531.

49. Villan E. Cardiac syncope in children. // Arch Pediatr 2004, 11: 169-174.

50. Chiu D.T., Shapiro N.I., Sun B.C. et al. Are echocardiography, telemetry, ambulatory electrocardiography monitoring, and cardiac enzymes in emergency department patients presenting with syncope useful tests? A preliminary investigation. // J Emerg Med. 2014, 47(1): 113-8.

51. Naschitz J, Rosner I. Orthostatic hypotension: framework of the syndrome. // Postgrad Med J. 2007, 83: 568574.

52. Parry S., Reeve P., Lawson J. et al. The Newcastle protocols 2008: un update on head-up tilt table testing and the management of vasovagal syncope and related disorders. // Heart 2009, 95: 416-420.

53. Raviele A., Giada F. Diagnistic accuracy of sublingual nitroglycerin test and low-dose isoproterenol test in patient with unexplained syncope. // Am J Cardiol 2000, 85: 1194-8.

54. Школенко Т., Школьникова М. Особенности рефлекторных (вазовагальных) синкопе у детей и подростков с нарушением функции синусового узла. // Педиатрия 2010, 89(3): 15-21.

55. Exercise standards for testing and training: a scientific statement from the American Heart Association. // Circulation 2013, 128: 873-934.

56. ACC/AHA guidelines for exercise testing. // J Am Coll Cardiol 1997, 30: 260-315.

57. Clinical Stress Testing in the Pediatric Age Group. // Circulation 2006, 113: 1905-1920.

58. Crawford M.H., Bernstein S.J., Deedwania P.C. et al. ACC/AHA guidelines for ambulatory electrocardiography: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). // J Am Coll Cardiol. 1999, 34: 912-48.

59. Mauriello D.A., Johnson J.N., Ackerman M.J. Holter monitoring in the evaluation of congenital long QT syndrome. // Pacing Clin Electrophysiol. 2011, 34: 11001104.

60. Тэйлор Р.Б. Трудный диагноз. В 2 ч. Том 2. Пер. с англ.-2-е изд., стереотип. - М.: Медицина, 1992, 592 с.

61. REVEAL XT9529 Имплантируемый кардиомонитор (Руководство врача), 2013, 103 c.

62. Babuty D., Pierre B., Clementy N. et al. Implantable loop recorder in clinical practice. Chapter: 09/2011; ISBN: 978-953-307-639-3. In electronic book: Cardiac Pacemakers - Biological Aspects, Clinical Applications and Possible Complications.

63. Iglesias J., Graf D., Pascale P. et al. The implantable loop recorder: a critical review. // Kardiovaskulare Medi/in 2009,12(3): 85-93.

64. Yeung B., McLeod Karen A. The implantable loop recorder in children. // Heart 2008, 94: 888-891.

65. Babikar A., Hynes B., Ward N. et al. A retrospective study of the clinical experience of the implantable loop recorder in a pediatric setting. // Int J Clin Pract. 2008, 62(10): 1520-1525.

66. Krahn A.D., Klein G.J., Yee R. et al. Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial. // J Am Coll Cardiol. 2003, 42: 495-501.

67. Farwell D.J., Freemantle N., Sulke N. The clinical impact of implantable loop recorders in patients with syncope. // Eur Heart J. 2006, 27: 351-6.

68. Providência R., Candeias R., Morais C. et al. Financial impact of adopting implantable loop recorder diagnostic for unexplained syncope compared with conventional diagnostic pathway in Portugal. // Cardiovascular Disorders 2014, 14: 63.

69. Edvardsson N., Wolff C., Tsintzos S. et al. Costs of unstructured investigation of unexplained syncope: insights from a micro-costing analysis of the observational PICTURE registry. // Europace 2015, 17 (7): 1141-8.

70. Subbarayan A., Ganesan B., Anbumani, Jayanthini. Temperamental traits of breathholding children: A case control study. // Indian J Psychiatry 2008, 50(3): 192-196.

71. Sawires H., Botrous O. Double-blind, placebo-controlled trial on the effect of piracetam on breath-holding spells. // Eur J Pediatr. 2012, 171(7): 1063-7.

72. Sartori S., Nosadini M., Leoni L. et al. Pacemaker in complicated and refractory breath-holding spells: When to think about it? // Brain Dev. 2015, 37: 2-12.

73. Odero A., Bozzani A., De Ferrari G.M., Schwartz P.J. Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy. // Heart Rhythm 2010, 7: 1161-1165.

74. De Ferrari G.M, Dusi V, Spazzolini C. et al. Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation. // Circulation 2015, 131: 2185-2193.

75. Leenhardt A., Lucet V., Denjoy I. et al. Catecholamin-ergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients. // Circulation 1995, 91: 1512-1519.

76. Hayashi M., Denjoy I., Extramiana F. et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. // Circulation 2009, 119: 2426-2434.

77. HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes // Heart Rhythm 2013, 10: 1932-1963.

78. Zipes D.P., Camm A.J., Borggrefe M. et al. ACC/ AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). // J Am Coll Cardiol. 2006, 48(5): 247-346.

79. Crosson, J.E., Callans D.J., Bradley D.J. et.al. PACES/ HRS Expert Consensus Statement on the Evaluation and Management of Ventricular Arrhythmias in the Child With a Structurally Normal Heart. // Heart Rhythm 2014, 11(9): e55-78.

80. Brugada J., Blom n., Sarquella-Brugada G.et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. // Europace 2013, 15 (9): 1337-1382.

81. Feltes T.F., Bacha E., Beekman R.H.III et al. Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease: A Scientific Statement From the American Heart Association. // Circulation 2011, 123: 26072652.